Article | Jotup

Mdxhealth's New Share Capital Amount and New Number of Shares

Retrieved on:

Friday, October 20, 2023

Leymus innovatus, Genomics, Disclosure, Acquisition, Genomic Health, American depositary receipt, Oncotype (Denmark), ADS, EUR, USD, Article, Security (finance)

IRVINE, CA, and HERSTAL, BELGIUM – October 20, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH) ("mdxhealth" or the "Company"), a commercial-stage precision diagnostics company, today a announces, in accordance with Article 15 of the Belgian Act of May 2, 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions, that in the context of a capital increase completed on October 20, 2023, the Company's share capital has increased from EUR 163,471,629.58 to EUR 164,302,752.89 and the number of issued and outstanding shares has increased from 270,380,936 to 272,880,936 ordinary shares, through the issuance of a total of 2,500,000 new shares.

Key Points:

IRVINE, CA, and HERSTAL, BELGIUM – October 20, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH) ("mdxhealth" or the "Company"), a commercial-stage precision diagnostics company, today a announces, in accordance with Article 15 of the Belgian Act of May 2, 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions, that in the context of a capital increase completed on October 20, 2023, the Company's share capital has increased from EUR 163,471,629.58 to EUR 164,302,752.89 and the number of issued and outstanding shares has increased from 270,380,936 to 272,880,936 ordinary shares, through the issuance of a total of 2,500,000 new shares.
The new shares were issued pursuant to the amendment, announced on August 23, 2023, to the asset purchase agreement for the acquisition by the Company of the Oncotype DX® GPS (Genomic Prostate Score®) test from Genomic Health, Inc. (a subsidiary of Exact Sciences Corporation).
In addition to the outstanding shares of the Company:
a total of 18,560,124 subscription rights of the Company are outstanding, which entitles their holders (assuming all subscription rights are granted and exercised) to subscribe to a total of 18,560,124 new shares with voting rights; and
under the loan and security agreement entered into by the Company and Innovatus Capital Partners in August 2022, Innovatus has the right to convert, prior to August 2, 2025, up to 15% of the outstanding principal amount of the loans (by means of a contribution in kind of the relevant payables due by the Company under the loans) into American Depositary Shares ("ADSs") of the Company (each representing 10 ordinary shares of the Company) at a conversion price per ADS equal to USD 11.21 (i.e., USD 1.121 per share on the basis of the ratio of 1 ADS per 10 shares).

Ferguson Share Repurchase Program - Weekly Report

Retrieved on:

Wednesday, October 25, 2023

Professional Services, HVAC, Other Construction & Property, Manufacturing, Finance, Construction & Property, Other Manufacturing, Treasury, Article, European Union (Withdrawal) Act 2018, Ferguson, Disclosure, Security (finance), EU

The Company intends to hold these shares in treasury.

Key Points:

The Company intends to hold these shares in treasury.
Following the purchase of these shares (including those purchased but not yet settled), the number of shares held by the Company in treasury will be 28,364,359.
Following the purchase of these shares, the remaining number of ordinary shares in issue will be 203,806,823.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, and the Commission Delegated Regulation (EU) 2016/1052, detailed information about the individual purchases can be found at Ferguson - Investors - Shareholder Center - Share Buy-Back Details - 2023 Share Buy-Back .

Alpha Copper Announces Non-Brokered Private Placement of Convertible Debentures and Consolidation of Common Shares

Retrieved on:

Wednesday, October 18, 2023

The Company is also pleased to announce a consolidation of the outstanding Common Shares on the basis of one post-consolidation Common Share for every four pre-consolidation Common Shares (the “Consolidation”).

Key Points:

The Company is also pleased to announce a consolidation of the outstanding Common Shares on the basis of one post-consolidation Common Share for every four pre-consolidation Common Shares (the “Consolidation”).
No fractional Common Shares will be issued as a result of the Consolidation.
Any fractional Common Shares more than one-half resulting from the Consolidation will be rounded up to the nearest whole Common Share, and any fractional shares less than one-half resulting from the Consolidation will be rounded down to the nearest whole Common Share.
Shareholder approval of the Consolidation is not required under the policies of the CSE nor under the Articles of the Company.

Teleperformance declares Offer for Majorel unconditional 98.45% of Shares tendered under the Offer – Opening of the Post-Acceptance Period

Retrieved on:

Friday, October 20, 2023

As a result, Teleperformance declares the Offer unconditional (doet gestand) and the Post-Acceptance Period will start as from 23 October 2023 for a 2-week period.

Key Points:

As a result, Teleperformance declares the Offer unconditional (doet gestand) and the Post-Acceptance Period will start as from 23 October 2023 for a 2-week period.
Shareholders who have elected to receive the Share Consideration during the Offer Period or the Post-Acceptance Period will receive on the Second Settlement Date Teleperformance shares at an exchange ratio of 30/217.
Further information on the Post-Acceptance Period is included in Section 5.8 (Post-Acceptance Period) of the Offer Memorandum.
A maximum of 4,608,295 Teleperformance shares is available for issue under the Share Consideration, (i.e., a maximum of 33,333,334 Shares can be exchanged for Teleperformance shares).

Ferguson Share Repurchase Program - Weekly Report

Retrieved on:

Wednesday, October 18, 2023

HVAC, Professional Services, Manufacturing, Finance, Treasury, Article, European Union (Withdrawal) Act 2018, Ferguson, Disclosure, Security (finance), EU

The Company intends to hold these shares in treasury.

Key Points:

The Company intends to hold these shares in treasury.
Following the purchase of these shares (including those purchased but not yet settled), the number of shares held by the Company in treasury will be 28,375,678.
Following the purchase of these shares, the remaining number of ordinary shares in issue will be 203,795,504.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, and the Commission Delegated Regulation (EU) 2016/1052, detailed information about the individual purchases can be found at Ferguson - Investors - Shareholder Center - Share Buy-Back Details - 2023 Share Buy-Back .

EQS-News: Kontron AG: Convocation of Extraordinary General Meeting

Retrieved on:

Wednesday, October 18, 2023

Only persons who are shareholders on the record date and can prove this to the Company shall be entitled to attend the General Meeting.

Key Points:

Only persons who are shareholders on the record date and can prove this to the Company shall be entitled to attend the General Meeting.
Insofar as Kontron AG uses external service providers to organise the General Meeting (e.g.
Any change in the number of treasury shares before the General Meeting and thereby in the total number of voting rights will be announced at the General Meeting.
This Extraordinary General Meeting is expected to have a short duration and so we ask for your understanding that the only refreshments provided will be in the form of drinks.

Alpine Banks of Colorado announces common shareholder dividend

Retrieved on:

Thursday, October 12, 2023

OTCQX, Article, Holding company

GLENWOOD SPRINGS, Colo, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Alpine Banks of Colorado (OTCQX: ALPIB) announced today that a quarterly cash dividend of $0.20 per Class B nonvoting common share will be paid on October 30, 2023, to shareholders of record at the close of business on October 23, 2023.

Key Points:

GLENWOOD SPRINGS, Colo, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Alpine Banks of Colorado (OTCQX: ALPIB) announced today that a quarterly cash dividend of $0.20 per Class B nonvoting common share will be paid on October 30, 2023, to shareholders of record at the close of business on October 23, 2023.
Alpine Banks of Colorado Class B nonvoting common shares are publicly traded on the OTCQX® Best Market under the symbol “ALPIB”.
Alpine Banks of Colorado Class A voting common shares are not publicly traded.
The dividend of $30.00 per Class A voting common share and $0.20 per Class B nonvoting common share is unchanged from the dividend paid in the previous quarter.

Hitachi Announces Consolidation of Healthcare Business into Hitachi High-Tech through Company Split

Retrieved on:

Thursday, October 12, 2023

TOKYO, Oct 12, 2023 - (JCN Newswire) - Hitachi, Ltd. (TSE:6501) and Hitachi High-Tech Corporation ("Hitachi High-Tech") today announced that they have decided to transfer Hitachi's Healthcare Business Division* to Hitachi High-Tech, a wholly owned subsidiary of Hitachi, through a company split effective April 1, 2024, for the purpose of strengthening the healthcare business in the Hitachi Group (the "Company Split").

Key Points:

TOKYO, Oct 12, 2023 - (JCN Newswire) - Hitachi, Ltd. (TSE:6501) and Hitachi High-Tech Corporation ("Hitachi High-Tech") today announced that they have decided to transfer Hitachi's Healthcare Business Division* to Hitachi High-Tech, a wholly owned subsidiary of Hitachi, through a company split effective April 1, 2024, for the purpose of strengthening the healthcare business in the Hitachi Group (the "Company Split").
Through the Company Split, Hitachi High-Tech will promote the healthcare business based on "Diagnosis x Treatment x Digital" and create healthcare innovation.
Since the Company Split is an absorption-type company split in which the business will be succeeded by a wholly owned subsidiary of Hitachi, disclosure regarding the Company Split in this announcement is simplified.
Hitachi and Hitachi High-Tech share the healthcare purpose "Innovating Healthcare, Embracing the Future" and arepromoting the healthcare business together.

Fuller, Smith & Turner PLC: Transaction in own securities

Retrieved on:

Tuesday, October 17, 2023

Transparency, Article, European Union (Withdrawal) Act 2018, FSA, Disclosure, Security (finance), Treasury, EU

The Company intends to hold the repurchased shares in Treasury.

Key Points:

The Company intends to hold the repurchased shares in Treasury.
Following the purchase of the said shares, Fuller’s listed issued share capital consists of 41,082,339 ‘A’ ordinary shares of 40p each.
Of this total, 2,963,079 ‘A’ ordinary shares are held in treasury.
Therefore, the total number of listed voting rights in the Company for the purpose of Disclosure and Transparency Rule 5.6.1 (calculated in accordance with Disclosure and Transparency Rule 5.6.2) is 38,119,260.

Cairn Homes Plc: Transaction in Own Shares

Retrieved on:

Tuesday, October 17, 2023

Euronext Dublin, EUR, London, Public limited company, Article, London Stock Exchange, Treasury, Share repurchase, Security (finance), EU

The Company announces that on 10 October 2023 it purchased a total of 181,384 of its ordinary shares of EUR 0.001 each (the "ordinary shares") on Euronext Dublin and the London Stock Exchange through the Company's broker Numis Securities Ltd, as detailed below.

Key Points:

The Company announces that on 10 October 2023 it purchased a total of 181,384 of its ordinary shares of EUR 0.001 each (the "ordinary shares") on Euronext Dublin and the London Stock Exchange through the Company's broker Numis Securities Ltd, as detailed below.
The repurchased shares will be cancelled.
Following settlement and cancellation of the above purchases, the Company's total number of ordinary shares in issue shall be 663,526,101 ordinary shares, each carrying the right to one vote.
The
Company holds nil ordinary shares in treasury.